OBJECTIVES: To determine whether hyperglycemia is related to prevalent frailty status in older women. DESIGN: Secondary data analysis of baseline data of a prospective cohort study. SETTING: Baltimore, Maryland. PARTICIPANTS: Five hundred forty-three women aged 70 to 79. METHODS: Research used baseline data from 543 participants in the Women's Health and Aging Studies I and II aged 70 to 79 who had all variables needed for analyses. The dependent variable was baseline frailty status (not frail, prefrail, frail), measured using an empirically derived model defining frailty according to weight loss, slow walking speed, weakness, exhaustion, and low activity (1-2 characteristics present=prefrail, > OR =3 =frail). Covariates included body mass index (BMI), interleukin-6 (IL-6), age, race, and several chronic diseases. Analyses included descriptive methods and multinomial logistic regression to adjust for key covariates. RESULTS: A hemoglobin A1c (HbA1c) level of 6.5% or greater in older women was significantly associated with higher likelihood of prefrail and frail status (normal HbA1c <6.0% was reference). The association between HbA1C levels of 6.0% to 6.5% and frailty status was not different from that of normal HbA1c, but HbA1c levels of 6.5% to 6.9% had nearly twice the likelihood of frailty (odds ratio (OR)=1.96, 95% confidence interval (CI)=1.47-2.59) as normal HbA1c. A HbA1c level of 9.0% or greater was also strongly associated (OR=2.57, 95% CI=1.99,3.32). Significant associations were also seen between baseline prefrail and frail status and low (18.5-20.0 kg/m2) and high (430.0 kg/m2) body mass index (BMI), interleukin-6, and all chronic diseases evaluated, but controlling for these covariates only minimally attenuated the independent association between HbA1c and frailty status. CONCLUSION: Hyperglycemia is associated with greater prevalence of prefrail and frail status; BMI, inflammation, and comorbidities do not explain the association. Longitudinal research and study of alternative pathways are needed.
OBJECTIVES: To determine whether hyperglycemia is related to prevalent frailty status in older women. DESIGN: Secondary data analysis of baseline data of a prospective cohort study. SETTING: Baltimore, Maryland. PARTICIPANTS: Five hundred forty-three women aged 70 to 79. METHODS: Research used baseline data from 543 participants in the Women's Health and Aging Studies I and II aged 70 to 79 who had all variables needed for analyses. The dependent variable was baseline frailty status (not frail, prefrail, frail), measured using an empirically derived model defining frailty according to weight loss, slow walking speed, weakness, exhaustion, and low activity (1-2 characteristics present=prefrail, > OR =3 =frail). Covariates included body mass index (BMI), interleukin-6 (IL-6), age, race, and several chronic diseases. Analyses included descriptive methods and multinomial logistic regression to adjust for key covariates. RESULTS: A hemoglobin A1c (HbA1c) level of 6.5% or greater in older women was significantly associated with higher likelihood of prefrail and frail status (normal HbA1c <6.0% was reference). The association between HbA1C levels of 6.0% to 6.5% and frailty status was not different from that of normal HbA1c, but HbA1c levels of 6.5% to 6.9% had nearly twice the likelihood of frailty (odds ratio (OR)=1.96, 95% confidence interval (CI)=1.47-2.59) as normal HbA1c. A HbA1c level of 9.0% or greater was also strongly associated (OR=2.57, 95% CI=1.99,3.32). Significant associations were also seen between baseline prefrail and frail status and low (18.5-20.0 kg/m2) and high (430.0 kg/m2) body mass index (BMI), interleukin-6, and all chronic diseases evaluated, but controlling for these covariates only minimally attenuated the independent association between HbA1c and frailty status. CONCLUSION:Hyperglycemia is associated with greater prevalence of prefrail and frail status; BMI, inflammation, and comorbidities do not explain the association. Longitudinal research and study of alternative pathways are needed.
Authors: A B Newman; J S Gottdiener; M A Mcburnie; C H Hirsch; W J Kop; R Tracy; J D Walston; L P Fried Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Stefano Volpato; Caroline Blaum; Helaine Resnick; Luigi Ferrucci; Linda P Fried; Jack M Guralnik Journal: Diabetes Care Date: 2002-04 Impact factor: 19.112
Authors: Caroline S Blaum; Qian Li Xue; Elisabete Michelon; Richard D Semba; Linda P Fried Journal: J Am Geriatr Soc Date: 2005-06 Impact factor: 5.562
Authors: Michael G Shlipak; Catherine Stehman-Breen; Linda F Fried; Xiao Song; David Siscovick; Linda P Fried; Bruce M Psaty; Anne B Newman Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Francesco Cipollone; Annalisa Iezzi; Maria Fazia; Mirco Zucchelli; Barbara Pini; Chiara Cuccurullo; Domenico De Cesare; Giovanni De Blasis; Raffaella Muraro; Roberto Bei; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti Journal: Circulation Date: 2003-08-11 Impact factor: 29.690
Authors: Dina Bellizzi; Patrizia D'Aquila; Alberto Montesanto; Andrea Corsonello; Vincenzo Mari; Bruno Mazzei; Fabrizia Lattanzio; Giuseppe Passarino Journal: Age (Dordr) Date: 2011-02-19
Authors: Anna M Kucharska-Newton; Priya Palta; Sheila Burgard; Michael E Griswold; Jennifer L Lund; Benjamin D Capistrant; Stephen B Kritchevsky; Karen Bandeen-Roche; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Alden L Gross; Michelle C Carlson; Nadia M Chu; Mara A McAdams-DeMarco; Dan Mungas; Eleanor M Simonsick; Ravi Varadhan; Qian-Li Xue; Jeremy Walston; Karen Bandeen-Roche Journal: Mech Ageing Dev Date: 2020-05-11 Impact factor: 5.432
Authors: Kristine M Erlandson; Jennifer A Schrack; Catherine M Jankowski; Todd T Brown; Thomas B Campbell Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071
Authors: Rita R Kalyani; Jing Tian; Qian-Li Xue; Jeremy Walston; Anne R Cappola; Linda P Fried; Frederick L Brancati; Caroline S Blaum Journal: J Am Geriatr Soc Date: 2012-08-10 Impact factor: 5.562